Quick Takeaways: Why It Matters? The UK launch of Scovella (velagliflozin oral solution) creates the first licensed, equine‑specific treatment for hyperinsulinemia, directly targeting the main driver behind most laminitis cases and shifting management from off‑la...
Quick Takeaways: Why It Matters? By putting TRUFORMA analyzers in equine clinics at no cost and offering free PPID testing cartridges to eligible Boehringer Ingelheim customers, the program makes it much easier and faster for vets to diagnose and monitor Cus...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
